| 0 |
REPERFUSION ARRHYTHMIA |
29 |
0.4754 |
| 1 |
REOCCLUSION |
26 |
0.3333 |
| 2 |
NIH STROKE SCALE SCORE INCREASED |
27 |
0.3253 |
| 3 |
NIH STROKE SCALE ABNORMAL |
10 |
0.3226 |
| 4 |
HAEMORRHAGIC TRANSFORMATION STROKE |
441 |
0.2926 |
| 5 |
CEREBRAL REPERFUSION INJURY |
7 |
0.2917 |
| 6 |
POSTINFARCTION ANGINA |
12 |
0.2222 |
| 7 |
CEREBRAL HYPERPERFUSION SYNDROME |
17 |
0.1868 |
| 8 |
FIBRINOLYSIS INCREASED |
7 |
0.1750 |
| 9 |
STROKE IN EVOLUTION |
37 |
0.1667 |
| 10 |
HAEMORRHAGIC INFARCTION |
76 |
0.1384 |
| 11 |
REPERFUSION INJURY |
16 |
0.1159 |
| 12 |
PRODUCT CLOSURE ISSUE |
63 |
0.1131 |
| 13 |
THROMBOLYSIS |
25 |
0.1126 |
| 14 |
NEUROLOGICAL DECOMPENSATION |
197 |
0.0851 |
| 15 |
HAEMORRHAGIC CEREBRAL INFARCTION |
57 |
0.0812 |
| 16 |
GINGIVAL BLEEDING |
1031 |
0.0754 |
| 17 |
TONGUE HAEMORRHAGE |
88 |
0.0750 |
| 18 |
INTERCEPTED PRODUCT STORAGE ERROR |
264 |
0.0739 |
| 19 |
FIBRINOLYSIS |
5 |
0.0735 |
| 20 |
BLOOD FIBRINOGEN DECREASED |
80 |
0.0701 |
| 21 |
CNS VENTRICULITIS |
21 |
0.0644 |
| 22 |
HERPES SIMPLEX VIRAEMIA |
7 |
0.0560 |
| 23 |
BRAIN MIDLINE SHIFT |
28 |
0.0527 |
| 24 |
INTERCEPTED MEDICATION ERROR |
244 |
0.0526 |
| 25 |
BRAIN STEM HAEMORRHAGE |
49 |
0.0518 |
| 26 |
HAEMORRHAGE INTRACRANIAL |
741 |
0.0495 |
| 27 |
MYOCARDIAL RUPTURE |
15 |
0.0493 |
| 28 |
BASILAR ARTERY OCCLUSION |
8 |
0.0482 |
| 29 |
CEREBRAL MASS EFFECT |
17 |
0.0468 |
| 30 |
EXTRAVASATION BLOOD |
11 |
0.0462 |
| 31 |
PROSTHETIC CARDIAC VALVE THROMBOSIS |
5 |
0.0459 |
| 32 |
RHEGMATOGENOUS RETINAL DETACHMENT |
9 |
0.0431 |
| 33 |
VESSEL PUNCTURE SITE HAEMATOMA |
8 |
0.0406 |
| 34 |
RHYTHM IDIOVENTRICULAR |
13 |
0.0400 |
| 35 |
CEREBRAL HAEMATOMA |
125 |
0.0372 |
| 36 |
PUNCTURE SITE HAEMORRHAGE |
26 |
0.0367 |
| 37 |
BRAIN HERNIATION |
105 |
0.0351 |
| 38 |
PARENTERAL NUTRITION |
8 |
0.0346 |
| 39 |
VERTEBRAL ARTERY DISSECTION |
7 |
0.0343 |
| 40 |
ACCELERATED IDIOVENTRICULAR RHYTHM |
5 |
0.0338 |
| 41 |
BULLOUS HAEMORRHAGIC DERMATOSIS |
7 |
0.0333 |
| 42 |
BASAL GANGLIA HAEMORRHAGE |
27 |
0.0332 |
| 43 |
BLOOD BRAIN BARRIER DEFECT |
5 |
0.0329 |
| 44 |
CORONARY REVASCULARISATION |
5 |
0.0316 |
| 45 |
TONGUE HAEMATOMA |
6 |
0.0303 |
| 46 |
LIVIDITY |
11 |
0.0300 |
| 47 |
RESTRICTIVE CARDIOMYOPATHY |
9 |
0.0297 |
| 48 |
APLASTIC ANAEMIA |
150 |
0.0287 |
| 49 |
CEREBELLAR HAEMATOMA |
8 |
0.0285 |
| 50 |
INTRAVENTRICULAR HAEMORRHAGE |
70 |
0.0281 |
| 51 |
CATHETER SITE HAEMATOMA |
8 |
0.0270 |
| 52 |
CEREBRAL ARTERY OCCLUSION |
28 |
0.0261 |
| 53 |
ARTERY DISSECTION |
10 |
0.0242 |
| 54 |
CHEST WALL HAEMATOMA |
6 |
0.0233 |
| 55 |
CEREBRAL HAEMORRHAGE |
827 |
0.0231 |
| 56 |
THROMBECTOMY |
7 |
0.0217 |
| 57 |
RETINAL PIGMENT EPITHELIAL TEAR |
15 |
0.0216 |
| 58 |
SUBCUTANEOUS HAEMATOMA |
26 |
0.0204 |
| 59 |
BASAL GANGLIA INFARCTION |
7 |
0.0203 |
| 60 |
HYPOFIBRINOGENAEMIA |
20 |
0.0202 |
| 61 |
TONGUE OEDEMA |
75 |
0.0196 |
| 62 |
CEREBRAL ARTERY THROMBOSIS |
10 |
0.0195 |
| 63 |
HYPHAEMA |
10 |
0.0192 |
| 64 |
UROGENITAL HAEMORRHAGE |
7 |
0.0188 |
| 65 |
MOUTH HAEMORRHAGE |
124 |
0.0169 |
| 66 |
COAGULATION TEST ABNORMAL |
13 |
0.0169 |
| 67 |
HAEMOTHORAX |
48 |
0.0165 |
| 68 |
CAROTID ARTERY DISSECTION |
7 |
0.0164 |
| 69 |
MACULAR HOLE |
22 |
0.0164 |
| 70 |
INTRACRANIAL HAEMATOMA |
9 |
0.0160 |
| 71 |
CARDIAC VENTRICULAR THROMBOSIS |
20 |
0.0155 |
| 72 |
CEREBRAL AMYLOID ANGIOPATHY |
5 |
0.0152 |
| 73 |
BRAIN COMPRESSION |
6 |
0.0150 |
| 74 |
COMPARTMENT SYNDROME |
39 |
0.0149 |
| 75 |
PERIPHERAL EMBOLISM |
17 |
0.0147 |
| 76 |
VITREOUS HAEMORRHAGE |
40 |
0.0145 |
| 77 |
TREATMENT DELAYED |
25 |
0.0144 |
| 78 |
CIRCUMORAL OEDEMA |
5 |
0.0143 |
| 79 |
ANGIOEDEMA |
631 |
0.0142 |
| 80 |
NO ADVERSE EVENT |
2541 |
0.0140 |
| 81 |
CATHETER SITE HAEMORRHAGE |
35 |
0.0140 |
| 82 |
SUBARACHNOID HAEMORRHAGE |
134 |
0.0131 |
| 83 |
HEMIANOPIA |
13 |
0.0131 |
| 84 |
RETROPERITONEAL HAEMORRHAGE |
32 |
0.0130 |
| 85 |
CEREBELLAR HAEMORRHAGE |
18 |
0.0126 |
| 86 |
VASOGENIC CEREBRAL OEDEMA |
9 |
0.0125 |
| 87 |
PERICARDIAL HAEMORRHAGE |
27 |
0.0123 |
| 88 |
CEREBRAL ARTERY EMBOLISM |
15 |
0.0123 |
| 89 |
VASCULAR PSEUDOANEURYSM |
21 |
0.0120 |
| 90 |
HAEMORRHAGIC STROKE |
94 |
0.0120 |
| 91 |
VENTRICULAR EXTRASYSTOLES |
123 |
0.0118 |
| 92 |
LIP HAEMORRHAGE |
15 |
0.0118 |
| 93 |
INTRACRANIAL MASS |
11 |
0.0116 |
| 94 |
CARDIAC DEATH |
14 |
0.0116 |
| 95 |
ELECTROCARDIOGRAM ST SEGMENT ELEVATION |
38 |
0.0115 |
| 96 |
POST THROMBOTIC SYNDROME |
5 |
0.0111 |
| 97 |
BRAIN OEDEMA |
136 |
0.0108 |
| 98 |
CENTRAL NERVOUS SYSTEM HAEMORRHAGE |
5 |
0.0107 |
| 99 |
ANAPHYLACTOID SHOCK |
5 |
0.0106 |
| 100 |
THALAMUS HAEMORRHAGE |
9 |
0.0103 |
| 101 |
EMBOLIC STROKE |
36 |
0.0102 |
| 102 |
EXTRAVASATION |
42 |
0.0102 |
| 103 |
PLATELET TRANSFUSION |
13 |
0.0101 |
| 104 |
ISCHAEMIC STROKE |
180 |
0.0101 |
| 105 |
INCISION SITE HAEMORRHAGE |
8 |
0.0099 |
| 106 |
BRAIN STEM INFARCTION |
10 |
0.0098 |
| 107 |
ALPHA HAEMOLYTIC STREPTOCOCCAL INFECTION |
9 |
0.0097 |
| 108 |
MUCOSAL HAEMORRHAGE |
11 |
0.0095 |
| 109 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
48 |
0.0093 |
| 110 |
CEREBRAL ISCHAEMIA |
48 |
0.0093 |
| 111 |
HAEMORRHAGE SUBCUTANEOUS |
33 |
0.0093 |
| 112 |
ABDOMINAL WALL HAEMATOMA |
18 |
0.0092 |
| 113 |
STREPTOCOCCAL BACTERAEMIA |
10 |
0.0092 |
| 114 |
INTERLEUKIN LEVEL INCREASED |
5 |
0.0091 |
| 115 |
CEREBRAL INFARCTION |
218 |
0.0089 |
| 116 |
RENAL VEIN THROMBOSIS |
6 |
0.0089 |
| 117 |
HEART TRANSPLANT |
8 |
0.0088 |
| 118 |
ANEURYSM RUPTURED |
8 |
0.0087 |
| 119 |
ECCHYMOSIS |
59 |
0.0086 |
| 120 |
RETROPERITONEAL HAEMATOMA |
19 |
0.0086 |
| 121 |
ENDOTRACHEAL INTUBATION COMPLICATION |
5 |
0.0085 |
| 122 |
VENA CAVA THROMBOSIS |
14 |
0.0084 |
| 123 |
JOINT CONTRACTURE |
9 |
0.0084 |
| 124 |
EXTRADURAL HAEMATOMA |
11 |
0.0083 |
| 125 |
DEVICE RELATED THROMBOSIS |
8 |
0.0081 |
| 126 |
HYDROCEPHALUS |
44 |
0.0081 |
| 127 |
AMPUTATION |
10 |
0.0080 |
| 128 |
PERITONEAL HAEMORRHAGE |
11 |
0.0079 |
| 129 |
VENTRICULAR TACHYCARDIA |
130 |
0.0079 |
| 130 |
PERIPHERAL ARTERY OCCLUSION |
11 |
0.0078 |
| 131 |
HYPERCHLORAEMIA |
5 |
0.0078 |
| 132 |
STRIDOR |
23 |
0.0078 |
| 133 |
VASOSPASM |
7 |
0.0076 |
| 134 |
BLOOD FIBRINOGEN INCREASED |
6 |
0.0076 |
| 135 |
ELECTROMECHANICAL DISSOCIATION |
6 |
0.0075 |
| 136 |
HAEMOPERITONEUM |
6 |
0.0075 |
| 137 |
EMBOLISM ARTERIAL |
9 |
0.0075 |
| 138 |
CRANIAL NERVE DISORDER |
5 |
0.0072 |
| 139 |
INTRA-ABDOMINAL HAEMORRHAGE |
17 |
0.0071 |
| 140 |
BRAIN DEATH |
22 |
0.0071 |
| 141 |
EMBOLISM |
59 |
0.0071 |
| 142 |
CAROTID ARTERY THROMBOSIS |
6 |
0.0071 |
| 143 |
CEREBRAL VENTRICLE DILATATION |
8 |
0.0069 |
| 144 |
CARDIAC TAMPONADE |
33 |
0.0069 |
| 145 |
VENTRICULAR FIBRILLATION |
77 |
0.0069 |
| 146 |
HEPARIN-INDUCED THROMBOCYTOPENIA |
34 |
0.0069 |
| 147 |
APALLIC SYNDROME |
5 |
0.0069 |
| 148 |
ISCHAEMIC CEREBRAL INFARCTION |
8 |
0.0069 |
| 149 |
NODAL RHYTHM |
10 |
0.0068 |
| 150 |
HEMIANOPIA HOMONYMOUS |
5 |
0.0068 |
| 151 |
DYSPHORIA |
34 |
0.0067 |
| 152 |
PRODUCT RECONSTITUTION QUALITY ISSUE |
6 |
0.0067 |
| 153 |
BRAIN STEM SYNDROME |
5 |
0.0067 |
| 154 |
PULMONARY ARTERY THROMBOSIS |
5 |
0.0065 |
| 155 |
ENDOTRACHEAL INTUBATION |
18 |
0.0064 |
| 156 |
HEMIPLEGIA |
53 |
0.0064 |
| 157 |
PERIPHERAL ISCHAEMIA |
26 |
0.0064 |
| 158 |
HAEMATOMA |
164 |
0.0063 |
| 159 |
BLOOD CREATINE PHOSPHOKINASE MB INCREASED |
8 |
0.0063 |
| 160 |
RENAL INFARCT |
9 |
0.0062 |
| 161 |
SUBDURAL HAEMORRHAGE |
17 |
0.0062 |
| 162 |
PERFORATION |
5 |
0.0062 |
| 163 |
INTRACARDIAC THROMBUS |
19 |
0.0062 |
| 164 |
HYPERPHOSPHATAEMIA |
13 |
0.0060 |
| 165 |
ADMINISTRATION SITE EXTRAVASATION |
6 |
0.0060 |
| 166 |
PULSELESS ELECTRICAL ACTIVITY |
25 |
0.0060 |
| 167 |
CEREBELLAR INFARCTION |
10 |
0.0059 |
| 168 |
CARDIOGENIC SHOCK |
84 |
0.0058 |
| 169 |
ATRIAL THROMBOSIS |
12 |
0.0058 |
| 170 |
SPLENIC INFARCTION |
10 |
0.0057 |
| 171 |
ARTERIAL THROMBOSIS |
11 |
0.0057 |
| 172 |
PHARYNGEAL HAEMORRHAGE |
7 |
0.0057 |
| 173 |
ISCHAEMIA |
26 |
0.0057 |
| 174 |
FIBRIN D DIMER INCREASED |
20 |
0.0056 |
| 175 |
INTRACRANIAL PRESSURE INCREASED |
31 |
0.0056 |
| 176 |
EMPYEMA |
11 |
0.0055 |
| 177 |
PRIMARY SEQUESTRUM |
5 |
0.0055 |
| 178 |
HAEMORRHAGE |
577 |
0.0055 |
| 179 |
INTESTINAL INFARCTION |
5 |
0.0055 |
| 180 |
SPLENIC RUPTURE |
9 |
0.0055 |
| 181 |
HAEMOGLOBINURIA |
6 |
0.0054 |
| 182 |
CATHETER SITE SWELLING |
5 |
0.0053 |
| 183 |
GAZE PALSY |
9 |
0.0053 |
| 184 |
INFECTIOUS PLEURAL EFFUSION |
8 |
0.0053 |
| 185 |
HEMIPARESIS |
89 |
0.0052 |
| 186 |
AMYLOIDOSIS |
9 |
0.0052 |
| 187 |
CARBON DIOXIDE DECREASED |
6 |
0.0052 |
| 188 |
CAROTID ARTERY OCCLUSION |
19 |
0.0052 |
| 189 |
VENTRICULAR ARRHYTHMIA |
19 |
0.0052 |
| 190 |
AORTIC DISSECTION |
21 |
0.0051 |
| 191 |
LARYNGEAL OEDEMA |
31 |
0.0050 |
| 192 |
VOCAL CORD PARALYSIS |
9 |
0.0050 |
| 193 |
EXTRASYSTOLES |
35 |
0.0050 |
| 194 |
LIP OEDEMA |
21 |
0.0050 |
| 195 |
HYPOGONADISM |
5 |
0.0049 |
| 196 |
AREFLEXIA |
13 |
0.0049 |
| 197 |
BLOOD LOSS ANAEMIA |
11 |
0.0049 |
| 198 |
CONSCIOUSNESS FLUCTUATING |
5 |
0.0048 |
| 199 |
SWOLLEN TONGUE |
149 |
0.0048 |
| 200 |
ENTEROCOCCAL BACTERAEMIA |
5 |
0.0047 |
| 201 |
INTRACRANIAL VENOUS SINUS THROMBOSIS |
5 |
0.0047 |
| 202 |
PRODUCT CONTAINER ISSUE |
40 |
0.0047 |
| 203 |
PROCEDURAL HAEMORRHAGE |
18 |
0.0046 |
| 204 |
PRODUCT NAME CONFUSION |
5 |
0.0046 |
| 205 |
EXTREMITY NECROSIS |
8 |
0.0046 |
| 206 |
THROMBOSIS IN DEVICE |
15 |
0.0046 |
| 207 |
PRODUCT STORAGE ERROR |
391 |
0.0045 |
| 208 |
KLEBSIELLA SEPSIS |
5 |
0.0044 |
| 209 |
MONOPARESIS |
8 |
0.0044 |
| 210 |
VENOOCCLUSIVE DISEASE |
11 |
0.0044 |
| 211 |
INFARCTION |
30 |
0.0044 |
| 212 |
VENTRICULAR HYPOKINESIA |
14 |
0.0044 |
| 213 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
22 |
0.0043 |
| 214 |
AORTIC THROMBOSIS |
5 |
0.0043 |
| 215 |
PUPILLARY REFLEX IMPAIRED |
8 |
0.0043 |
| 216 |
PERIPHERAL ARTERY THROMBOSIS |
6 |
0.0043 |
| 217 |
VASCULAR OCCLUSION |
9 |
0.0043 |
| 218 |
BRADYARRHYTHMIA |
7 |
0.0043 |
| 219 |
PELVIC VENOUS THROMBOSIS |
6 |
0.0042 |
| 220 |
HAEMATOMA MUSCLE |
5 |
0.0042 |
| 221 |
BLEEDING TIME PROLONGED |
5 |
0.0041 |
| 222 |
PULMONARY HAEMORRHAGE |
32 |
0.0041 |
| 223 |
APLASIA |
8 |
0.0041 |
| 224 |
PUPIL FIXED |
7 |
0.0040 |
| 225 |
BLOOD UREA DECREASED |
5 |
0.0040 |
| 226 |
PLEURITIC PAIN |
11 |
0.0040 |
| 227 |
CEREBROVASCULAR DISORDER |
12 |
0.0040 |
| 228 |
OEDEMA MOUTH |
13 |
0.0040 |
| 229 |
HAEMORRHAGE URINARY TRACT |
10 |
0.0039 |
| 230 |
BLOOD PRESSURE IMMEASURABLE |
6 |
0.0039 |
| 231 |
RETINAL DETACHMENT |
36 |
0.0039 |
| 232 |
ANTICOAGULATION DRUG LEVEL ABOVE THERAPEUTIC |
6 |
0.0039 |
| 233 |
QUADRIPLEGIA |
8 |
0.0039 |
| 234 |
COAGULATION TIME PROLONGED |
6 |
0.0039 |
| 235 |
ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT |
10 |
0.0039 |
| 236 |
COAGULOPATHY |
64 |
0.0038 |
| 237 |
LIVEDO RETICULARIS |
8 |
0.0038 |
| 238 |
HAEMODYNAMIC INSTABILITY |
29 |
0.0038 |
| 239 |
INCORRECT PRODUCT STORAGE |
50 |
0.0038 |
| 240 |
ADENOVIRUS INFECTION |
11 |
0.0038 |
| 241 |
GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT |
8 |
0.0038 |
| 242 |
HYPERCOAGULATION |
7 |
0.0037 |
| 243 |
ISCHAEMIC HEPATITIS |
5 |
0.0036 |
| 244 |
RETINAL HAEMORRHAGE |
26 |
0.0036 |
| 245 |
NEPHROGENIC SYSTEMIC FIBROSIS |
11 |
0.0036 |
| 246 |
LEG AMPUTATION |
15 |
0.0036 |
| 247 |
ATRIOVENTRICULAR BLOCK SECOND DEGREE |
11 |
0.0036 |
| 248 |
QUADRIPARESIS |
6 |
0.0036 |
| 249 |
PARESIS |
8 |
0.0036 |
| 250 |
N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED |
5 |
0.0036 |
| 251 |
SUPRAVENTRICULAR EXTRASYSTOLES |
12 |
0.0035 |
| 252 |
INJECTION SITE OEDEMA |
6 |
0.0035 |
| 253 |
METHAEMOGLOBINAEMIA |
8 |
0.0035 |
| 254 |
NEUTROPENIC COLITIS |
7 |
0.0034 |
| 255 |
INFUSION SITE EXTRAVASATION |
21 |
0.0034 |
| 256 |
JUGULAR VEIN THROMBOSIS |
6 |
0.0034 |
| 257 |
SPINAL CORD COMPRESSION |
13 |
0.0033 |
| 258 |
VENOUS OCCLUSION |
6 |
0.0033 |
| 259 |
INCORRECT DRUG ADMINISTRATION RATE |
14 |
0.0033 |
| 260 |
CONTRAINDICATION TO MEDICAL TREATMENT |
5 |
0.0033 |
| 261 |
PRODUCT PREPARATION ERROR |
67 |
0.0033 |
| 262 |
VENOOCCLUSIVE LIVER DISEASE |
16 |
0.0032 |
| 263 |
ANAPHYLACTOID REACTION |
13 |
0.0032 |
| 264 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
53 |
0.0031 |
| 265 |
TRANSFUSION |
33 |
0.0031 |
| 266 |
CYTOKINE RELEASE SYNDROME |
63 |
0.0031 |
| 267 |
ATRIOVENTRICULAR BLOCK COMPLETE |
21 |
0.0031 |
| 268 |
ATELECTASIS |
30 |
0.0031 |
| 269 |
OCCULT BLOOD POSITIVE |
6 |
0.0031 |
| 270 |
FACIAL PARALYSIS |
26 |
0.0030 |
| 271 |
ACUTE RESPIRATORY FAILURE |
58 |
0.0030 |
| 272 |
HYPERNATRAEMIA |
15 |
0.0030 |
| 273 |
MUSCLE HAEMORRHAGE |
12 |
0.0030 |
| 274 |
HYPERCAPNIA |
9 |
0.0030 |
| 275 |
CORONARY ARTERY THROMBOSIS |
6 |
0.0030 |
| 276 |
EMBOLISM VENOUS |
9 |
0.0030 |
| 277 |
SHOCK |
68 |
0.0030 |
| 278 |
HAEMATURIA |
101 |
0.0029 |
| 279 |
TACHYPNOEA |
40 |
0.0029 |
| 280 |
INJECTION SITE EXTRAVASATION |
36 |
0.0029 |
| 281 |
DEVICE OCCLUSION |
41 |
0.0029 |
| 282 |
SINUS BRADYCARDIA |
28 |
0.0029 |
| 283 |
IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME |
17 |
0.0029 |
| 284 |
SHOCK HAEMORRHAGIC |
23 |
0.0028 |
| 285 |
PRODUCT CONTAMINATION |
10 |
0.0028 |
| 286 |
NEUROLOGICAL SYMPTOM |
16 |
0.0028 |
| 287 |
MUCOSAL INFLAMMATION |
73 |
0.0028 |
| 288 |
BRADYCARDIA |
147 |
0.0028 |
| 289 |
PRODUCT PREPARATION ISSUE |
18 |
0.0027 |
| 290 |
PULSE ABSENT |
13 |
0.0027 |
| 291 |
RIGHT VENTRICULAR FAILURE |
19 |
0.0027 |
| 292 |
BACTERAEMIA |
32 |
0.0027 |
| 293 |
APHASIA |
81 |
0.0027 |
| 294 |
ANGIOPATHY |
15 |
0.0027 |
| 295 |
SINUS TACHYCARDIA |
38 |
0.0027 |
| 296 |
RESPIRATORY FAILURE |
195 |
0.0027 |
| 297 |
MULTI-ORGAN FAILURE |
46 |
0.0027 |
| 298 |
CENTRAL VENOUS CATHETERISATION |
8 |
0.0026 |
| 299 |
LIP SWELLING |
88 |
0.0026 |
| 300 |
PNEUMONIA ASPIRATION |
66 |
0.0026 |
| 301 |
ACUTE MYOCARDIAL INFARCTION |
77 |
0.0026 |
| 302 |
VIITH NERVE PARALYSIS |
9 |
0.0026 |
| 303 |
HAEMATEMESIS |
66 |
0.0026 |
| 304 |
ESCHERICHIA BACTERAEMIA |
6 |
0.0025 |
| 305 |
COMA |
121 |
0.0025 |
| 306 |
HYPERAEMIA |
5 |
0.0025 |
| 307 |
STAPHYLOCOCCAL BACTERAEMIA |
11 |
0.0025 |
| 308 |
CONJUNCTIVAL HYPERAEMIA |
9 |
0.0025 |
| 309 |
HAEMOPTYSIS |
70 |
0.0025 |
| 310 |
FAILURE TO THRIVE |
13 |
0.0025 |
| 311 |
CEREBRAL THROMBOSIS |
7 |
0.0025 |
| 312 |
VASCULAR GRAFT |
7 |
0.0024 |
| 313 |
SKIN INDURATION |
5 |
0.0024 |
| 314 |
PROTEIN TOTAL DECREASED |
9 |
0.0024 |
| 315 |
ATRIAL FLUTTER |
19 |
0.0024 |
| 316 |
DILATATION VENTRICULAR |
5 |
0.0024 |
| 317 |
SUBDURAL HAEMATOMA |
34 |
0.0024 |
| 318 |
PROTHROMBIN TIME PROLONGED |
14 |
0.0023 |
| 319 |
ARTERIOSCLEROSIS |
22 |
0.0023 |
| 320 |
AORTIC ARTERIOSCLEROSIS |
6 |
0.0023 |
| 321 |
RESPIRATORY DISTRESS |
64 |
0.0023 |
| 322 |
SPUTUM INCREASED |
5 |
0.0023 |
| 323 |
HYPOVOLAEMIC SHOCK |
11 |
0.0023 |
| 324 |
HYPOXIC-ISCHAEMIC ENCEPHALOPATHY |
6 |
0.0023 |
| 325 |
CEREBRAL ATROPHY |
9 |
0.0023 |
| 326 |
HYPOXIA |
78 |
0.0022 |
| 327 |
CLONUS |
6 |
0.0022 |
| 328 |
HYPOPHOSPHATAEMIA |
16 |
0.0022 |
| 329 |
OBSTRUCTIVE AIRWAYS DISORDER |
24 |
0.0022 |
| 330 |
OFF LABEL USE |
1883 |
0.0021 |
| 331 |
CARDIAC ARREST |
175 |
0.0021 |
| 332 |
OXYGEN SATURATION ABNORMAL |
6 |
0.0021 |
| 333 |
TUMOUR HAEMORRHAGE |
6 |
0.0021 |
| 334 |
CONJUNCTIVAL HAEMORRHAGE |
8 |
0.0021 |
| 335 |
ACIDOSIS |
16 |
0.0021 |
| 336 |
METASTATIC NEOPLASM |
9 |
0.0021 |
| 337 |
PARAPLEGIA |
6 |
0.0021 |
| 338 |
RALES |
12 |
0.0021 |
| 339 |
APNOEA |
16 |
0.0021 |
| 340 |
PULMONARY EMBOLISM |
195 |
0.0020 |
| 341 |
HYPOVOLAEMIA |
12 |
0.0020 |
| 342 |
PETECHIAE |
21 |
0.0020 |
| 343 |
HYPERPARATHYROIDISM SECONDARY |
5 |
0.0020 |
| 344 |
DISSEMINATED INTRAVASCULAR COAGULATION |
28 |
0.0020 |
| 345 |
BLOOD PRESSURE SYSTOLIC DECREASED |
9 |
0.0020 |
| 346 |
HAEMORRHAGIC DIATHESIS |
7 |
0.0020 |
| 347 |
INTENTIONAL PRODUCT USE ISSUE |
172 |
0.0020 |
| 348 |
INTRAOCULAR PRESSURE INCREASED |
25 |
0.0020 |
| 349 |
FIBROSIS |
6 |
0.0019 |
| 350 |
BONE LESION |
7 |
0.0019 |
| 351 |
BLOOD PHOSPHORUS DECREASED |
7 |
0.0019 |
| 352 |
CYANOSIS |
30 |
0.0019 |
| 353 |
EYE MOVEMENT DISORDER |
13 |
0.0019 |
| 354 |
RADICULOPATHY |
5 |
0.0019 |
| 355 |
SERUM FERRITIN INCREASED |
10 |
0.0019 |
| 356 |
CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR |
64 |
0.0019 |
| 357 |
DYSARTHRIA |
71 |
0.0019 |
| 358 |
BLOOD CREATINE PHOSPHOKINASE INCREASED |
54 |
0.0019 |
| 359 |
ENCEPHALOPATHY |
46 |
0.0019 |
| 360 |
LOOSE TOOTH |
6 |
0.0019 |
| 361 |
FEBRILE NEUTROPENIA |
122 |
0.0018 |
| 362 |
INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS |
10 |
0.0018 |
| 363 |
MENTAL STATUS CHANGES |
51 |
0.0018 |
| 364 |
MEDICATION ERROR |
102 |
0.0018 |
| 365 |
GASTROINTESTINAL HAEMORRHAGE |
153 |
0.0018 |
| 366 |
DEPRESSED LEVEL OF CONSCIOUSNESS |
72 |
0.0018 |
| 367 |
DEVICE RELATED INFECTION |
28 |
0.0018 |
| 368 |
ANAPHYLACTIC REACTION |
100 |
0.0018 |
| 369 |
ANEURYSM |
9 |
0.0018 |
| 370 |
NO THERAPEUTIC RESPONSE |
22 |
0.0018 |
| 371 |
CARDIOPULMONARY FAILURE |
7 |
0.0018 |
| 372 |
LUNG CONSOLIDATION |
5 |
0.0018 |
| 373 |
VENOUS THROMBOSIS |
7 |
0.0018 |
| 374 |
PNEUMONIA FUNGAL |
7 |
0.0018 |
| 375 |
HAEMATOCRIT DECREASED |
35 |
0.0018 |
| 376 |
PHLEBITIS |
9 |
0.0018 |
| 377 |
MYOCARDIAL ISCHAEMIA |
20 |
0.0018 |
| 378 |
CEREBRAL DISORDER |
13 |
0.0018 |
| 379 |
LEFT VENTRICULAR FAILURE |
6 |
0.0017 |
| 380 |
BUNDLE BRANCH BLOCK RIGHT |
8 |
0.0017 |
| 381 |
HYPOTENSION |
347 |
0.0017 |
| 382 |
LOCALISED OEDEMA |
8 |
0.0017 |
| 383 |
NEPHROGENIC ANAEMIA |
8 |
0.0017 |
| 384 |
EPISTAXIS |
129 |
0.0017 |
| 385 |
SEPTIC SHOCK |
75 |
0.0017 |
| 386 |
DEEP VEIN THROMBOSIS |
112 |
0.0017 |
| 387 |
CAROTID ARTERY STENOSIS |
6 |
0.0017 |
| 388 |
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE |
7 |
0.0017 |
| 389 |
ABORTION |
5 |
0.0017 |
| 390 |
LUMBAR SPINAL STENOSIS |
5 |
0.0017 |
| 391 |
TUMOUR LYSIS SYNDROME |
15 |
0.0017 |
| 392 |
SKIN TIGHTNESS |
8 |
0.0017 |
| 393 |
SKIN ABRASION |
8 |
0.0017 |
| 394 |
ANGINA UNSTABLE |
11 |
0.0017 |
| 395 |
PERICARDIAL EFFUSION |
39 |
0.0017 |
| 396 |
CONGESTIVE CARDIOMYOPATHY |
7 |
0.0017 |
| 397 |
GANGRENE |
10 |
0.0017 |
| 398 |
LEUKOCYTOSIS |
30 |
0.0017 |
| 399 |
CARDIAC FAILURE ACUTE |
11 |
0.0016 |
| 400 |
PURULENT DISCHARGE |
7 |
0.0016 |
| 401 |
INTESTINAL ISCHAEMIA |
9 |
0.0016 |
| 402 |
POST PROCEDURAL HAEMORRHAGE |
19 |
0.0016 |
| 403 |
ANAPHYLACTIC SHOCK |
42 |
0.0016 |
| 404 |
UNRESPONSIVE TO STIMULI |
42 |
0.0016 |
| 405 |
PHARYNGEAL OEDEMA |
25 |
0.0016 |
| 406 |
BRAIN NATRIURETIC PEPTIDE INCREASED |
5 |
0.0016 |
| 407 |
PORTAL HYPERTENSION |
5 |
0.0016 |
| 408 |
ACUTE PULMONARY OEDEMA |
9 |
0.0016 |
| 409 |
URINE OUTPUT DECREASED |
14 |
0.0016 |
| 410 |
NEUROTOXICITY |
28 |
0.0016 |
| 411 |
ELECTROENCEPHALOGRAM ABNORMAL |
5 |
0.0016 |
| 412 |
INTERNATIONAL NORMALISED RATIO INCREASED |
45 |
0.0016 |
| 413 |
PATHOLOGICAL FRACTURE |
8 |
0.0016 |
| 414 |
SUPRAVENTRICULAR TACHYCARDIA |
15 |
0.0016 |
| 415 |
ENDOCARDITIS |
8 |
0.0016 |
| 416 |
ASPIRATION |
17 |
0.0016 |
| 417 |
PULMONARY HYPERTENSION |
32 |
0.0015 |
| 418 |
INJECTION SITE INFECTION |
5 |
0.0015 |
| 419 |
INFUSION SITE HAEMORRHAGE |
5 |
0.0015 |
| 420 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
43 |
0.0015 |
| 421 |
PULMONARY OEDEMA |
67 |
0.0015 |
| 422 |
POTENTIATING DRUG INTERACTION |
5 |
0.0015 |
| 423 |
METASTASES TO SPINE |
5 |
0.0015 |
| 424 |
GINGIVITIS |
8 |
0.0015 |
| 425 |
COLITIS ISCHAEMIC |
10 |
0.0015 |
| 426 |
ARRHYTHMIA |
70 |
0.0015 |
| 427 |
DECUBITUS ULCER |
12 |
0.0015 |
| 428 |
ACUTE RESPIRATORY DISTRESS SYNDROME |
26 |
0.0015 |
| 429 |
HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS |
11 |
0.0015 |
| 430 |
CEREBROVASCULAR ACCIDENT |
248 |
0.0015 |
| 431 |
CHEST PAIN |
270 |
0.0015 |
| 432 |
INTERNATIONAL NORMALISED RATIO ABNORMAL |
5 |
0.0015 |
| 433 |
OLIGURIA |
9 |
0.0014 |
| 434 |
ENCEPHALITIS |
10 |
0.0014 |
| 435 |
RED CELL DISTRIBUTION WIDTH INCREASED |
6 |
0.0014 |
| 436 |
EPSTEIN-BARR VIRUS INFECTION |
9 |
0.0014 |
| 437 |
COVID-19 PNEUMONIA |
17 |
0.0014 |
| 438 |
PROCEDURAL COMPLICATION |
11 |
0.0014 |
| 439 |
PRODUCT LEAKAGE |
8 |
0.0014 |
| 440 |
CLOSTRIDIUM DIFFICILE COLITIS |
15 |
0.0014 |
| 441 |
MITRAL VALVE INCOMPETENCE |
16 |
0.0014 |
| 442 |
BRONCHOSPASM |
20 |
0.0014 |
| 443 |
HIATUS HERNIA |
18 |
0.0014 |
| 444 |
PNEUMOTHORAX |
22 |
0.0014 |
| 445 |
CARDIO-RESPIRATORY ARREST |
58 |
0.0014 |
| 446 |
DEATH |
1194 |
0.0014 |
| 447 |
TRICUSPID VALVE INCOMPETENCE |
11 |
0.0014 |
| 448 |
PULMONARY FUNCTION TEST DECREASED |
6 |
0.0014 |
| 449 |
BLOOD PRESSURE DECREASED |
91 |
0.0014 |
| 450 |
OXYGEN SATURATION DECREASED |
76 |
0.0014 |
| 451 |
MENINGITIS |
9 |
0.0013 |
| 452 |
PRODUCT COMPLAINT |
34 |
0.0013 |
| 453 |
BLOOD CALCIUM DECREASED |
15 |
0.0013 |
| 454 |
SKIN LACERATION |
14 |
0.0013 |
| 455 |
ANURIA |
11 |
0.0013 |
| 456 |
ARTERIAL OCCLUSIVE DISEASE |
10 |
0.0013 |
| 457 |
BLOOD ALBUMIN DECREASED |
10 |
0.0013 |
| 458 |
SPINAL OSTEOARTHRITIS |
11 |
0.0013 |
| 459 |
ALTERED STATE OF CONSCIOUSNESS |
27 |
0.0012 |
| 460 |
LUNG INFILTRATION |
11 |
0.0012 |
| 461 |
COMPLICATION ASSOCIATED WITH DEVICE |
18 |
0.0012 |
| 462 |
SEPSIS |
138 |
0.0012 |
| 463 |
INTERNATIONAL NORMALISED RATIO DECREASED |
5 |
0.0012 |
| 464 |
INTERCEPTED PRODUCT PREPARATION ERROR |
15 |
0.0012 |
| 465 |
CORONARY ARTERY BYPASS |
7 |
0.0012 |
| 466 |
PALLOR |
33 |
0.0012 |
| 467 |
ATRIAL FIBRILLATION |
118 |
0.0012 |
| 468 |
STRESS CARDIOMYOPATHY |
7 |
0.0012 |
| 469 |
BRAIN INJURY |
12 |
0.0012 |
| 470 |
PARALYSIS |
17 |
0.0012 |
| 471 |
TROPONIN INCREASED |
9 |
0.0012 |
| 472 |
HYPERPYREXIA |
5 |
0.0012 |
| 473 |
HAEMOGLOBIN DECREASED |
120 |
0.0012 |
| 474 |
ATRIOVENTRICULAR BLOCK |
9 |
0.0012 |
| 475 |
RESPIRATORY ARREST |
32 |
0.0012 |
| 476 |
HYPERBILIRUBINAEMIA |
12 |
0.0012 |
| 477 |
INJECTION SITE VESICLES |
7 |
0.0012 |
| 478 |
STATUS EPILEPTICUS |
13 |
0.0011 |
| 479 |
HYPERTRANSAMINASAEMIA |
8 |
0.0011 |
| 480 |
SUDDEN DEATH |
12 |
0.0011 |
| 481 |
ABDOMINAL ABSCESS |
5 |
0.0011 |
| 482 |
GASTRIC HAEMORRHAGE |
13 |
0.0011 |
| 483 |
COMPRESSION FRACTURE |
6 |
0.0011 |
| 484 |
DRUG ADMINISTRATION ERROR |
34 |
0.0011 |
| 485 |
UPPER-AIRWAY COUGH SYNDROME |
9 |
0.0011 |
| 486 |
ACUTE CORONARY SYNDROME |
9 |
0.0011 |
| 487 |
PLEURAL EFFUSION |
66 |
0.0011 |
| 488 |
BLOOD PRESSURE DIASTOLIC INCREASED |
5 |
0.0011 |
| 489 |
BLOOD UREA INCREASED |
18 |
0.0011 |
| 490 |
MALNUTRITION |
12 |
0.0011 |
| 491 |
PULMONARY CONGESTION |
14 |
0.0011 |
| 492 |
CARDIAC FAILURE |
85 |
0.0011 |
| 493 |
GENERALISED OEDEMA |
13 |
0.0010 |
| 494 |
DRUG INTERACTION |
166 |
0.0010 |
| 495 |
RESPIRATORY DISORDER |
31 |
0.0010 |
| 496 |
WRONG PRODUCT ADMINISTERED |
7 |
0.0010 |
| 497 |
TACHYCARDIA |
92 |
0.0010 |
| 498 |
EYELID OEDEMA |
12 |
0.0010 |
| 499 |
SKIN WARM |
6 |
0.0010 |
| 500 |
HYPOALBUMINAEMIA |
8 |
0.0010 |
| 501 |
BLOOD PRESSURE SYSTOLIC INCREASED |
20 |
0.0010 |
| 502 |
ASCITES |
30 |
0.0010 |
| 503 |
CENTRAL NERVOUS SYSTEM LESION |
14 |
0.0010 |
| 504 |
CHEST DISCOMFORT |
104 |
0.0010 |
| 505 |
BREATH SOUNDS ABNORMAL |
5 |
0.0010 |
| 506 |
STAPHYLOCOCCAL SEPSIS |
5 |
0.0010 |
| 507 |
HYPERVOLAEMIA |
5 |
0.0010 |
| 508 |
ORGANISING PNEUMONIA |
5 |
0.0010 |
| 509 |
ODYNOPHAGIA |
6 |
0.0010 |
| 510 |
PANCYTOPENIA |
56 |
0.0010 |
| 511 |
OEDEMA |
54 |
0.0010 |
| 512 |
HEPATIC FAILURE |
30 |
0.0010 |
| 513 |
CORONARY ARTERY STENOSIS |
5 |
0.0010 |
| 514 |
KLEBSIELLA INFECTION |
5 |
0.0010 |
| 515 |
PNEUMONIA BACTERIAL |
9 |
0.0010 |
| 516 |
NEUTROPENIC SEPSIS |
7 |
0.0010 |
| 517 |
HYPOKALAEMIA |
45 |
0.0010 |
| 518 |
GRAFT VERSUS HOST DISEASE |
7 |
0.0010 |
| 519 |
STAPHYLOCOCCAL INFECTION |
32 |
0.0010 |
| 520 |
NERVOUS SYSTEM DISORDER |
30 |
0.0010 |
| 521 |
FLANK PAIN |
9 |
0.0010 |
| 522 |
PRODUCT QUALITY ISSUE |
130 |
0.0010 |
| 523 |
RESTLESSNESS |
35 |
0.0010 |
| 524 |
PARTIAL SEIZURES |
5 |
0.0010 |
| 525 |
BLOOD LACTIC ACID INCREASED |
5 |
0.0009 |
| 526 |
THROMBOCYTOPENIA |
106 |
0.0009 |
| 527 |
LOWER GASTROINTESTINAL HAEMORRHAGE |
7 |
0.0009 |
| 528 |
ELECTROLYTE IMBALANCE |
11 |
0.0009 |
| 529 |
THROMBOSIS |
76 |
0.0009 |
| 530 |
NYSTAGMUS |
5 |
0.0009 |
| 531 |
CIRCULATORY COLLAPSE |
16 |
0.0009 |
| 532 |
VITAMIN D DEFICIENCY |
9 |
0.0009 |
| 533 |
ACUTE KIDNEY INJURY |
141 |
0.0009 |
| 534 |
HYPERTHERMIA |
7 |
0.0009 |
| 535 |
HEPATOMEGALY |
9 |
0.0009 |
| 536 |
CARDIAC FAILURE CONGESTIVE |
73 |
0.0009 |
| 537 |
HAEMOLYSIS |
7 |
0.0009 |
| 538 |
RESPIRATORY RATE INCREASED |
8 |
0.0009 |
| 539 |
ACUTE MYELOID LEUKAEMIA |
14 |
0.0009 |
| 540 |
LEFT VENTRICULAR DYSFUNCTION |
6 |
0.0009 |
| 541 |
PNEUMONIA |
290 |
0.0009 |
| 542 |
SMALL INTESTINAL OBSTRUCTION |
11 |
0.0009 |
| 543 |
MOTOR DYSFUNCTION |
9 |
0.0009 |
| 544 |
SEIZURE |
102 |
0.0009 |
| 545 |
INTERNAL HAEMORRHAGE |
10 |
0.0009 |
| 546 |
ANGINA PECTORIS |
25 |
0.0009 |
| 547 |
RENAL FAILURE ACUTE |
37 |
0.0009 |
| 548 |
SENSORY LOSS |
7 |
0.0009 |
| 549 |
IRON DEFICIENCY ANAEMIA |
8 |
0.0009 |
| 550 |
MOUTH SWELLING |
5 |
0.0009 |
| 551 |
GRAND MAL CONVULSION |
8 |
0.0009 |
| 552 |
TENDERNESS |
9 |
0.0009 |
| 553 |
BLOOD PRESSURE INCREASED |
132 |
0.0009 |
| 554 |
BACTERIAL INFECTION |
16 |
0.0009 |
| 555 |
ASPHYXIA |
7 |
0.0009 |
| 556 |
PERIPHERAL SENSORY NEUROPATHY |
5 |
0.0009 |
| 557 |
POOR QUALITY PRODUCT ADMINISTERED |
9 |
0.0009 |
| 558 |
HAIR DISORDER |
7 |
0.0008 |
| 559 |
LYMPHOCYTE COUNT DECREASED |
15 |
0.0008 |
| 560 |
HYPERHIDROSIS |
108 |
0.0008 |
| 561 |
ENDOPHTHALMITIS |
5 |
0.0008 |
| 562 |
OSTEOMYELITIS |
15 |
0.0008 |
| 563 |
SPEECH DISORDER |
43 |
0.0008 |
| 564 |
EPILEPSY |
25 |
0.0008 |
| 565 |
CARDIOMEGALY |
10 |
0.0008 |
| 566 |
PAIN IN JAW |
23 |
0.0008 |
| 567 |
DYSPHAGIA |
77 |
0.0008 |
| 568 |
HYPERGLYCAEMIA |
29 |
0.0008 |
| 569 |
INFUSION SITE SWELLING |
5 |
0.0008 |
| 570 |
RECTAL HAEMORRHAGE |
34 |
0.0008 |
| 571 |
AORTIC ANEURYSM |
6 |
0.0008 |
| 572 |
WRONG DRUG ADMINISTERED |
7 |
0.0008 |
| 573 |
METABOLIC ACIDOSIS |
25 |
0.0008 |
| 574 |
NEUTROPHIL COUNT INCREASED |
8 |
0.0008 |
| 575 |
ANAEMIA |
149 |
0.0008 |
| 576 |
POST PROCEDURAL COMPLICATION |
15 |
0.0008 |
| 577 |
RENAL FAILURE CHRONIC |
6 |
0.0008 |
| 578 |
EJECTION FRACTION DECREASED |
12 |
0.0008 |
| 579 |
BONE DISORDER |
14 |
0.0008 |
| 580 |
ELECTROCARDIOGRAM ABNORMAL |
6 |
0.0008 |
| 581 |
UROSEPSIS |
7 |
0.0008 |
| 582 |
BLOOD LACTATE DEHYDROGENASE INCREASED |
12 |
0.0008 |
| 583 |
DEFORMITY |
7 |
0.0007 |
| 584 |
TREATMENT FAILURE |
62 |
0.0007 |
| 585 |
MYASTHENIA GRAVIS |
6 |
0.0007 |
| 586 |
PRODUCT ADMINISTRATION ERROR |
15 |
0.0007 |
| 587 |
PRODUCT PACKAGING ISSUE |
7 |
0.0007 |
| 588 |
VOMITING |
345 |
0.0007 |
| 589 |
HICCUPS |
6 |
0.0007 |
| 590 |
PERIPHERAL COLDNESS |
10 |
0.0007 |
| 591 |
MELAENA |
16 |
0.0007 |
| 592 |
GENERALISED TONIC-CLONIC SEIZURE |
12 |
0.0007 |
| 593 |
HYPERCHOLESTEROLAEMIA |
7 |
0.0007 |
| 594 |
MYOCARDIAL INFARCTION |
126 |
0.0007 |
| 595 |
SECOND PRIMARY MALIGNANCY |
6 |
0.0007 |
| 596 |
HYPOMAGNESAEMIA |
10 |
0.0007 |
| 597 |
PYREXIA |
247 |
0.0007 |
| 598 |
RENAL TUBULAR NECROSIS |
7 |
0.0007 |
| 599 |
SENSATION OF FOREIGN BODY |
6 |
0.0007 |
| 600 |
CARDIOVASCULAR DISORDER |
18 |
0.0007 |
| 601 |
LUNG INFECTION |
11 |
0.0007 |
| 602 |
HYPOPHAGIA |
18 |
0.0007 |
| 603 |
DERMATITIS CONTACT |
8 |
0.0007 |
| 604 |
HYPOTONIA |
7 |
0.0007 |
| 605 |
PREGNANCY |
14 |
0.0007 |
| 606 |
BLOOD POTASSIUM DECREASED |
21 |
0.0007 |
| 607 |
SKIN HYPERPIGMENTATION |
6 |
0.0007 |
| 608 |
LETHARGY |
40 |
0.0007 |
| 609 |
PSYCHOLOGICAL TRAUMA |
6 |
0.0007 |
| 610 |
DERMATITIS BULLOUS |
5 |
0.0007 |
| 611 |
ABSCESS |
11 |
0.0007 |
| 612 |
MADAROSIS |
8 |
0.0007 |
| 613 |
RESPIRATORY SYNCYTIAL VIRUS INFECTION |
6 |
0.0007 |
| 614 |
BONE MARROW FAILURE |
14 |
0.0007 |
| 615 |
FLUID OVERLOAD |
10 |
0.0007 |
| 616 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
17 |
0.0007 |
| 617 |
ORAL DISORDER |
5 |
0.0007 |
| 618 |
PURPURA |
6 |
0.0007 |
| 619 |
SKIN HAEMORRHAGE |
10 |
0.0007 |
| 620 |
ORAL PAIN |
15 |
0.0007 |
| 621 |
HAEMOLYTIC ANAEMIA |
6 |
0.0007 |
| 622 |
CYTOPENIA |
8 |
0.0007 |
| 623 |
FACE OEDEMA |
11 |
0.0007 |
| 624 |
BRONCHOPULMONARY ASPERGILLOSIS |
5 |
0.0006 |
| 625 |
HAIR COLOUR CHANGES |
8 |
0.0006 |
| 626 |
PLATELET COUNT DECREASED |
68 |
0.0006 |
| 627 |
DYSPNOEA EXERTIONAL |
24 |
0.0006 |
| 628 |
COLITIS |
24 |
0.0006 |
| 629 |
GENERAL PHYSICAL HEALTH DETERIORATION |
73 |
0.0006 |
| 630 |
FURUNCLE |
5 |
0.0006 |
| 631 |
LOCAL SWELLING |
11 |
0.0006 |
| 632 |
HYPERTENSIVE CRISIS |
7 |
0.0006 |
| 633 |
HYPERTENSION |
133 |
0.0006 |
| 634 |
COLD SWEAT |
11 |
0.0006 |
| 635 |
NEPHROPATHY TOXIC |
7 |
0.0006 |
| 636 |
MYDRIASIS |
8 |
0.0006 |
| 637 |
VAGINAL HAEMORRHAGE |
27 |
0.0006 |
| 638 |
DYSPNOEA |
349 |
0.0006 |
| 639 |
POLYURIA |
5 |
0.0006 |
| 640 |
PULMONARY MASS |
9 |
0.0006 |
| 641 |
END STAGE RENAL DISEASE |
11 |
0.0006 |
| 642 |
WHITE BLOOD CELL COUNT INCREASED |
23 |
0.0006 |
| 643 |
HAEMODIALYSIS |
5 |
0.0006 |
| 644 |
PERICARDITIS |
10 |
0.0006 |
| 645 |
CONVULSION |
34 |
0.0006 |
| 646 |
DRUG EFFECT DECREASED |
32 |
0.0006 |
| 647 |
STOMATITIS |
36 |
0.0006 |
| 648 |
INFUSION SITE ERYTHEMA |
5 |
0.0006 |
| 649 |
TRANSIENT ISCHAEMIC ATTACK |
20 |
0.0006 |
| 650 |
HYPERSENSITIVITY |
110 |
0.0006 |
| 651 |
BLOOD BILIRUBIN INCREASED |
16 |
0.0006 |
| 652 |
ATAXIA |
7 |
0.0006 |
| 653 |
MUSCULAR WEAKNESS |
67 |
0.0006 |
| 654 |
TOOTH ABSCESS |
6 |
0.0006 |
| 655 |
HYPERLIPIDAEMIA |
7 |
0.0006 |
| 656 |
POLYNEUROPATHY |
7 |
0.0006 |
| 657 |
CORONARY ARTERY OCCLUSION |
8 |
0.0006 |
| 658 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
105 |
0.0006 |
| 659 |
BLOOD CREATININE INCREASED |
38 |
0.0006 |
| 660 |
TEMPERATURE INTOLERANCE |
6 |
0.0006 |
| 661 |
HYPOCALCAEMIA |
11 |
0.0006 |
| 662 |
POOR VENOUS ACCESS |
6 |
0.0006 |
| 663 |
PERITONITIS |
12 |
0.0006 |
| 664 |
CARDIAC MURMUR |
5 |
0.0006 |
| 665 |
ADRENAL INSUFFICIENCY |
7 |
0.0006 |
| 666 |
DELIRIUM |
20 |
0.0006 |
| 667 |
PRESYNCOPE |
14 |
0.0006 |
| 668 |
GLAUCOMA |
11 |
0.0006 |
| 669 |
RESPIRATORY DEPRESSION |
7 |
0.0006 |
| 670 |
HYPERCALCAEMIA |
7 |
0.0006 |
| 671 |
IMMUNOSUPPRESSION |
5 |
0.0006 |
| 672 |
LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR |
5 |
0.0006 |
| 673 |
RENAL FAILURE |
75 |
0.0006 |
| 674 |
HAEMORRHOIDS |
11 |
0.0006 |
| 675 |
CONTRAINDICATED PRODUCT ADMINISTERED |
17 |
0.0006 |
| 676 |
RED BLOOD CELL COUNT DECREASED |
16 |
0.0006 |
| 677 |
NEUROPATHY PERIPHERAL |
53 |
0.0006 |
| 678 |
INJECTION SITE HAEMATOMA |
8 |
0.0006 |
| 679 |
CLOSTRIDIUM DIFFICILE INFECTION |
12 |
0.0005 |
| 680 |
GASTROENTERITIS |
8 |
0.0005 |
| 681 |
DEVICE ISSUE |
49 |
0.0005 |
| 682 |
OEDEMA PERIPHERAL |
66 |
0.0005 |
| 683 |
INTERVERTEBRAL DISC DEGENERATION |
5 |
0.0005 |
| 684 |
BODY TEMPERATURE INCREASED |
11 |
0.0005 |
| 685 |
CONFUSIONAL STATE |
87 |
0.0005 |
| 686 |
CHILLS |
63 |
0.0005 |
| 687 |
PLATELET COUNT INCREASED |
7 |
0.0005 |
| 688 |
RASH PAPULAR |
12 |
0.0005 |
| 689 |
INFUSION RELATED REACTION |
35 |
0.0005 |
| 690 |
SPUTUM DISCOLOURED |
5 |
0.0005 |
| 691 |
OSTEOPENIA |
8 |
0.0005 |
| 692 |
HAIR TEXTURE ABNORMAL |
7 |
0.0005 |
| 693 |
MUSCLE TWITCHING |
12 |
0.0005 |
| 694 |
NEUTROPHIL COUNT DECREASED |
21 |
0.0005 |
| 695 |
HEART RATE DECREASED |
18 |
0.0005 |
| 696 |
HEPATIC FUNCTION ABNORMAL |
19 |
0.0005 |
| 697 |
MYOCLONUS |
6 |
0.0005 |
| 698 |
BLINDNESS UNILATERAL |
7 |
0.0005 |
| 699 |
LACTIC ACIDOSIS |
16 |
0.0005 |
| 700 |
AGITATION |
36 |
0.0005 |
| 701 |
DRUG INEFFECTIVE |
646 |
0.0005 |
| 702 |
OSTEONECROSIS OF JAW |
12 |
0.0005 |
| 703 |
HYPERKALAEMIA |
17 |
0.0005 |
| 704 |
DEVICE MALFUNCTION |
34 |
0.0005 |
| 705 |
PULMONARY ARTERIAL HYPERTENSION |
7 |
0.0005 |
| 706 |
ILEUS |
6 |
0.0005 |
| 707 |
UPPER RESPIRATORY TRACT INFECTION |
22 |
0.0005 |
| 708 |
MUSCLE ATROPHY |
6 |
0.0005 |
| 709 |
GASTRIC ULCER |
9 |
0.0005 |
| 710 |
URINARY INCONTINENCE |
14 |
0.0005 |
| 711 |
NAUSEA |
372 |
0.0005 |
| 712 |
RETCHING |
10 |
0.0005 |
| 713 |
SCAR |
8 |
0.0005 |
| 714 |
MUSCULOSKELETAL DISCOMFORT |
8 |
0.0005 |
| 715 |
FLUSHING |
47 |
0.0005 |
| 716 |
DYSURIA |
17 |
0.0005 |
| 717 |
RESPIRATORY TRACT INFECTION |
12 |
0.0005 |
| 718 |
URTICARIA |
77 |
0.0005 |
| 719 |
MENTAL DISORDER |
20 |
0.0005 |
| 720 |
PRODUCT DISPENSING ERROR |
10 |
0.0005 |
| 721 |
ANHEDONIA |
12 |
0.0005 |
| 722 |
GASTRITIS |
12 |
0.0005 |
| 723 |
DISABILITY |
9 |
0.0005 |
| 724 |
BLOOD TRIGLYCERIDES INCREASED |
8 |
0.0005 |
| 725 |
NEURALGIA |
11 |
0.0005 |
| 726 |
MUSCULOSKELETAL CHEST PAIN |
7 |
0.0005 |
| 727 |
THERAPY PARTIAL RESPONDER |
7 |
0.0004 |
| 728 |
JOINT RANGE OF MOTION DECREASED |
6 |
0.0004 |
| 729 |
SWELLING FACE |
29 |
0.0004 |
| 730 |
PNEUMONITIS |
12 |
0.0004 |
| 731 |
ULCER |
7 |
0.0004 |
| 732 |
HEART RATE INCREASED |
43 |
0.0004 |
| 733 |
ASPARTATE AMINOTRANSFERASE INCREASED |
23 |
0.0004 |
| 734 |
LOSS OF CONSCIOUSNESS |
55 |
0.0004 |
| 735 |
INFECTION |
62 |
0.0004 |
| 736 |
ABDOMINAL PAIN |
99 |
0.0004 |
| 737 |
HEPATOCELLULAR INJURY |
6 |
0.0004 |
| 738 |
FRACTURE |
8 |
0.0004 |
| 739 |
WHEEZING |
25 |
0.0004 |
| 740 |
MUSCULOSKELETAL DISORDER |
8 |
0.0004 |
| 741 |
LIMB DISCOMFORT |
13 |
0.0004 |
| 742 |
CHOLECYSTITIS |
5 |
0.0004 |
| 743 |
URINARY RETENTION |
14 |
0.0004 |
| 744 |
SLEEP APNOEA SYNDROME |
8 |
0.0004 |
| 745 |
IMPAIRED QUALITY OF LIFE |
6 |
0.0004 |
| 746 |
RENAL IMPAIRMENT |
35 |
0.0004 |
| 747 |
OSTEOPOROSIS |
17 |
0.0004 |
| 748 |
HEADACHE |
259 |
0.0004 |
| 749 |
NEUTROPENIA |
56 |
0.0004 |
| 750 |
CARDIOMYOPATHY |
6 |
0.0004 |
| 751 |
DISEASE PROGRESSION |
48 |
0.0004 |
| 752 |
CONTUSION |
39 |
0.0004 |
| 753 |
SINUS DISORDER |
8 |
0.0004 |
| 754 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
21 |
0.0004 |
| 755 |
HYPOAESTHESIA ORAL |
6 |
0.0004 |
| 756 |
PRODUCTIVE COUGH |
19 |
0.0004 |
| 757 |
DERMATITIS ALLERGIC |
5 |
0.0004 |
| 758 |
CORONARY ARTERY DISEASE |
12 |
0.0004 |
| 759 |
DEVICE FAILURE |
6 |
0.0004 |
| 760 |
ALANINE AMINOTRANSFERASE INCREASED |
24 |
0.0004 |
| 761 |
INFUSION SITE PAIN |
5 |
0.0004 |
| 762 |
METASTASES TO CENTRAL NERVOUS SYSTEM |
5 |
0.0004 |
| 763 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
9 |
0.0004 |
| 764 |
RESTLESS LEGS SYNDROME |
7 |
0.0004 |
| 765 |
C-REACTIVE PROTEIN INCREASED |
14 |
0.0004 |
| 766 |
SARS-COV-2 TEST POSITIVE |
5 |
0.0004 |
| 767 |
OSTEOARTHRITIS |
16 |
0.0004 |
| 768 |
CONJUNCTIVITIS |
7 |
0.0004 |
| 769 |
OBESITY |
6 |
0.0004 |
| 770 |
DYSPHONIA |
22 |
0.0004 |
| 771 |
COUGH |
104 |
0.0004 |
| 772 |
MUSCLE TIGHTNESS |
6 |
0.0004 |
| 773 |
THROAT TIGHTNESS |
10 |
0.0004 |
| 774 |
CHRONIC KIDNEY DISEASE |
28 |
0.0004 |
| 775 |
METASTASES TO BONE |
6 |
0.0004 |
| 776 |
PULMONARY FIBROSIS |
7 |
0.0004 |
| 777 |
ASTHENIA |
137 |
0.0004 |
| 778 |
HYPOAESTHESIA |
54 |
0.0004 |
| 779 |
DISCOMFORT |
22 |
0.0004 |
| 780 |
ORAL DISCOMFORT |
5 |
0.0004 |
| 781 |
RASH MACULO-PAPULAR |
8 |
0.0004 |
| 782 |
FEELING COLD |
10 |
0.0004 |
| 783 |
BACK PAIN |
83 |
0.0004 |
| 784 |
THERAPY NON-RESPONDER |
16 |
0.0004 |
| 785 |
CANDIDA INFECTION |
6 |
0.0004 |
| 786 |
HYPONATRAEMIA |
20 |
0.0004 |
| 787 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
6 |
0.0003 |
| 788 |
PAIN |
214 |
0.0003 |
| 789 |
NEOPLASM MALIGNANT |
23 |
0.0003 |
| 790 |
LIVER FUNCTION TEST ABNORMAL |
10 |
0.0003 |
| 791 |
MOVEMENT DISORDER |
11 |
0.0003 |
| 792 |
METASTASES TO LIVER |
6 |
0.0003 |
| 793 |
TOOTH LOSS |
7 |
0.0003 |
| 794 |
CELLULITIS |
17 |
0.0003 |
| 795 |
MATERNAL EXPOSURE DURING PREGNANCY |
30 |
0.0003 |
| 796 |
IMMUNODEFICIENCY |
5 |
0.0003 |
| 797 |
ABDOMINAL DISTENSION |
35 |
0.0003 |
| 798 |
IMPAIRED HEALING |
11 |
0.0003 |
| 799 |
ELECTROCARDIOGRAM QT PROLONGED |
12 |
0.0003 |
| 800 |
ECONOMIC PROBLEM |
5 |
0.0003 |
| 801 |
ILL-DEFINED DISORDER |
20 |
0.0003 |
| 802 |
INJURY |
23 |
0.0003 |
| 803 |
SKIN DISCOLOURATION |
15 |
0.0003 |
| 804 |
MUSCULOSKELETAL PAIN |
17 |
0.0003 |
| 805 |
DEHYDRATION |
43 |
0.0003 |
| 806 |
DEVICE DISLOCATION |
14 |
0.0003 |
| 807 |
CONDITION AGGRAVATED |
97 |
0.0003 |
| 808 |
BLOOD SODIUM DECREASED |
6 |
0.0003 |
| 809 |
URINARY TRACT INFECTION |
54 |
0.0003 |
| 810 |
BLOOD URINE PRESENT |
6 |
0.0003 |
| 811 |
SENSORY DISTURBANCE |
5 |
0.0003 |
| 812 |
ERYTHEMA |
64 |
0.0003 |
| 813 |
BLOOD POTASSIUM INCREASED |
5 |
0.0003 |
| 814 |
SOMNOLENCE |
62 |
0.0003 |
| 815 |
SKIN FISSURES |
6 |
0.0003 |
| 816 |
DEAFNESS |
8 |
0.0003 |
| 817 |
LABORATORY TEST ABNORMAL |
9 |
0.0003 |
| 818 |
JOINT STIFFNESS |
8 |
0.0003 |
| 819 |
WHITE BLOOD CELL COUNT DECREASED |
33 |
0.0003 |
| 820 |
DISORIENTATION |
12 |
0.0003 |
| 821 |
PANCREATITIS |
16 |
0.0003 |
| 822 |
BLOOD PRESSURE ABNORMAL |
6 |
0.0003 |
| 823 |
EXPIRED PRODUCT ADMINISTERED |
10 |
0.0003 |
| 824 |
SKIN DISORDER |
10 |
0.0003 |
| 825 |
DEVICE LEAKAGE |
13 |
0.0003 |
| 826 |
SWELLING |
28 |
0.0003 |
| 827 |
ANXIETY |
85 |
0.0003 |
| 828 |
PRODUCT USE ISSUE |
56 |
0.0003 |
| 829 |
THERAPEUTIC RESPONSE DECREASED |
18 |
0.0003 |
| 830 |
FEEDING DISORDER |
6 |
0.0003 |
| 831 |
RASH ERYTHEMATOUS |
14 |
0.0003 |
| 832 |
DEVICE DEFECTIVE |
5 |
0.0003 |
| 833 |
NECK PAIN |
16 |
0.0003 |
| 834 |
EOSINOPHILIA |
5 |
0.0003 |
| 835 |
LIVER INJURY |
7 |
0.0003 |
| 836 |
COVID-19 |
50 |
0.0003 |
| 837 |
CYSTITIS |
9 |
0.0003 |
| 838 |
PLASMA CELL MYELOMA |
11 |
0.0003 |
| 839 |
HIP FRACTURE |
9 |
0.0003 |
| 840 |
INCORRECT ROUTE OF DRUG ADMINISTRATION |
10 |
0.0003 |
| 841 |
CONSTIPATION |
61 |
0.0003 |
| 842 |
PARAESTHESIA |
44 |
0.0003 |
| 843 |
FEELING HOT |
17 |
0.0003 |
| 844 |
OSTEONECROSIS |
9 |
0.0003 |
| 845 |
RASH |
119 |
0.0003 |
| 846 |
VISUAL ACUITY REDUCED |
9 |
0.0003 |
| 847 |
SKIN ULCER |
7 |
0.0003 |
| 848 |
BLINDNESS |
11 |
0.0003 |
| 849 |
STEVENS-JOHNSON SYNDROME |
6 |
0.0003 |
| 850 |
TRANSAMINASES INCREASED |
6 |
0.0003 |
| 851 |
DIPLOPIA |
7 |
0.0003 |
| 852 |
RENAL INJURY |
8 |
0.0003 |
| 853 |
AGRANULOCYTOSIS |
5 |
0.0003 |
| 854 |
PAIN IN EXTREMITY |
79 |
0.0003 |
| 855 |
GLOSSODYNIA |
6 |
0.0003 |
| 856 |
HEPATIC CIRRHOSIS |
5 |
0.0003 |
| 857 |
LUNG DISORDER |
13 |
0.0003 |
| 858 |
OROPHARYNGEAL PAIN |
24 |
0.0003 |
| 859 |
RENAL DISORDER |
12 |
0.0003 |
| 860 |
RASH MACULAR |
9 |
0.0003 |
| 861 |
BRONCHITIS |
19 |
0.0003 |
| 862 |
CARDIAC DISORDER |
24 |
0.0003 |
| 863 |
EMOTIONAL DISTRESS |
31 |
0.0003 |
| 864 |
SKIN LESION |
7 |
0.0003 |
| 865 |
HAEMATOCHEZIA |
14 |
0.0003 |
| 866 |
PERIPHERAL SWELLING |
39 |
0.0003 |
| 867 |
HEAD INJURY |
8 |
0.0003 |
| 868 |
DISEASE RECURRENCE |
12 |
0.0003 |
| 869 |
BLOOD PRESSURE FLUCTUATION |
6 |
0.0002 |
| 870 |
BLISTER |
14 |
0.0002 |
| 871 |
DIZZINESS |
124 |
0.0002 |
| 872 |
GASTROOESOPHAGEAL REFLUX DISEASE |
20 |
0.0002 |
| 873 |
MENTAL IMPAIRMENT |
6 |
0.0002 |
| 874 |
MALIGNANT NEOPLASM PROGRESSION |
25 |
0.0002 |
| 875 |
PRURITUS |
93 |
0.0002 |
| 876 |
DECREASED APPETITE |
56 |
0.0002 |
| 877 |
OVERDOSE |
52 |
0.0002 |
| 878 |
INTESTINAL OBSTRUCTION |
9 |
0.0002 |
| 879 |
MOBILITY DECREASED |
17 |
0.0002 |
| 880 |
COGNITIVE DISORDER |
11 |
0.0002 |
| 881 |
DRUG EXPOSURE DURING PREGNANCY |
8 |
0.0002 |
| 882 |
LIVER FUNCTION TEST INCREASED |
5 |
0.0002 |
| 883 |
PRURITUS GENERALISED |
5 |
0.0002 |
| 884 |
EMOTIONAL DISORDER |
7 |
0.0002 |
| 885 |
LYMPHADENOPATHY |
8 |
0.0002 |
| 886 |
HALLUCINATION |
17 |
0.0002 |
| 887 |
SINUSITIS |
23 |
0.0002 |
| 888 |
DYSPEPSIA |
22 |
0.0002 |
| 889 |
CHROMATURIA |
5 |
0.0002 |
| 890 |
HYPOTHYROIDISM |
7 |
0.0002 |
| 891 |
CATARACT |
13 |
0.0002 |
| 892 |
FATIGUE |
169 |
0.0002 |
| 893 |
DIVERTICULITIS |
6 |
0.0002 |
| 894 |
WOUND |
6 |
0.0002 |
| 895 |
VIRAL INFECTION |
7 |
0.0002 |
| 896 |
SYNCOPE |
21 |
0.0002 |
| 897 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
42 |
0.0002 |
| 898 |
HYPOGLYCAEMIA |
10 |
0.0002 |
| 899 |
PALPITATIONS |
24 |
0.0002 |
| 900 |
DIARRHOEA |
132 |
0.0002 |
| 901 |
PSYCHOTIC DISORDER |
6 |
0.0002 |
| 902 |
LIVER DISORDER |
9 |
0.0002 |
| 903 |
RHINORRHOEA |
13 |
0.0002 |
| 904 |
BURNING SENSATION |
14 |
0.0002 |
| 905 |
INCORRECT DOSE ADMINISTERED |
45 |
0.0002 |
| 906 |
NEPHROLITHIASIS |
9 |
0.0002 |
| 907 |
ACCIDENTAL EXPOSURE TO PRODUCT |
20 |
0.0002 |
| 908 |
FEMUR FRACTURE |
6 |
0.0002 |
| 909 |
VISUAL IMPAIRMENT |
24 |
0.0002 |
| 910 |
ALOPECIA |
38 |
0.0002 |
| 911 |
WRONG TECHNIQUE IN DEVICE USAGE PROCESS |
9 |
0.0002 |
| 912 |
WEIGHT DECREASED |
53 |
0.0002 |
| 913 |
VISION BLURRED |
26 |
0.0002 |
| 914 |
NIGHT SWEATS |
6 |
0.0002 |
| 915 |
FEAR |
5 |
0.0002 |
| 916 |
UNEVALUABLE EVENT |
14 |
0.0002 |
| 917 |
CHOLELITHIASIS |
6 |
0.0002 |
| 918 |
THERAPEUTIC PRODUCT EFFECT INCOMPLETE |
13 |
0.0002 |
| 919 |
AGGRESSION |
9 |
0.0002 |
| 920 |
DEMENTIA |
5 |
0.0002 |
| 921 |
UNDERDOSE |
13 |
0.0002 |
| 922 |
GAIT DISTURBANCE |
34 |
0.0002 |
| 923 |
TREMOR |
29 |
0.0002 |
| 924 |
NEOPLASM PROGRESSION |
6 |
0.0002 |
| 925 |
DYSKINESIA |
7 |
0.0002 |
| 926 |
BONE PAIN |
10 |
0.0002 |
| 927 |
ARTHRALGIA |
70 |
0.0002 |
| 928 |
FALL |
56 |
0.0002 |
| 929 |
GASTROINTESTINAL DISORDER |
15 |
0.0002 |
| 930 |
EYE SWELLING |
6 |
0.0002 |
| 931 |
LEUKOPENIA |
8 |
0.0002 |
| 932 |
MUSCLE SPASMS |
29 |
0.0002 |
| 933 |
AMNESIA |
10 |
0.0002 |
| 934 |
NASAL CONGESTION |
9 |
0.0002 |
| 935 |
DRY SKIN |
20 |
0.0001 |
| 936 |
GAIT INABILITY |
5 |
0.0001 |
| 937 |
PRODUCT USE IN UNAPPROVED INDICATION |
37 |
0.0001 |
| 938 |
DISTURBANCE IN ATTENTION |
8 |
0.0001 |
| 939 |
EXTRA DOSE ADMINISTERED |
6 |
0.0001 |
| 940 |
INSOMNIA |
39 |
0.0001 |
| 941 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
8 |
0.0001 |
| 942 |
COMPLETED SUICIDE |
12 |
0.0001 |
| 943 |
RHABDOMYOLYSIS |
6 |
0.0001 |
| 944 |
BLOOD GLUCOSE INCREASED |
27 |
0.0001 |
| 945 |
SYSTEMIC LUPUS ERYTHEMATOSUS |
5 |
0.0001 |
| 946 |
DEPRESSION |
32 |
0.0001 |
| 947 |
ARTHRITIS |
11 |
0.0001 |
| 948 |
HYPOACUSIS |
6 |
0.0001 |
| 949 |
MALAISE |
61 |
0.0001 |
| 950 |
INJECTION SITE HAEMORRHAGE |
11 |
0.0001 |
| 951 |
FLUID RETENTION |
7 |
0.0001 |
| 952 |
MIGRAINE |
13 |
0.0001 |
| 953 |
ABDOMINAL PAIN UPPER |
28 |
0.0001 |
| 954 |
ILLNESS |
14 |
0.0001 |
| 955 |
INFLAMMATION |
7 |
0.0001 |
| 956 |
HEPATIC ENZYME INCREASED |
9 |
0.0001 |
| 957 |
HOSPITALISATION |
20 |
0.0001 |
| 958 |
EXPOSURE DURING PREGNANCY |
8 |
0.0001 |
| 959 |
ABNORMAL BEHAVIOUR |
5 |
0.0001 |
| 960 |
EYE PAIN |
7 |
0.0001 |
| 961 |
LUNG NEOPLASM MALIGNANT |
5 |
0.0001 |
| 962 |
SURGERY |
7 |
0.0001 |
| 963 |
MEMORY IMPAIRMENT |
16 |
0.0001 |
| 964 |
WEIGHT INCREASED |
26 |
0.0001 |
| 965 |
DRUG INTOLERANCE |
11 |
0.0001 |
| 966 |
RASH PRURITIC |
6 |
0.0001 |
| 967 |
LOWER RESPIRATORY TRACT INFECTION |
5 |
0.0001 |
| 968 |
MYALGIA |
18 |
0.0001 |
| 969 |
OCULAR HYPERAEMIA |
5 |
0.0001 |
| 970 |
DIABETES MELLITUS |
8 |
0.0001 |
| 971 |
HERPES ZOSTER |
6 |
0.0001 |
| 972 |
BALANCE DISORDER |
9 |
0.0001 |
| 973 |
LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES |
5 |
0.0001 |
| 974 |
INTERSTITIAL LUNG DISEASE |
5 |
0.0001 |
| 975 |
INTENTIONAL PRODUCT MISUSE |
9 |
0.0001 |
| 976 |
IRRITABILITY |
6 |
0.0001 |
| 977 |
PRODUCT DOSE OMISSION ISSUE |
29 |
0.0001 |
| 978 |
HOT FLUSH |
7 |
0.0001 |
| 979 |
NASOPHARYNGITIS |
17 |
0.0001 |
| 980 |
ASTHMA |
10 |
0.0001 |
| 981 |
THERAPY INTERRUPTED |
6 |
0.0001 |
| 982 |
SKIN EXFOLIATION |
7 |
0.0001 |
| 983 |
FEELING ABNORMAL |
19 |
0.0001 |
| 984 |
ABDOMINAL DISCOMFORT |
13 |
0.0001 |
| 985 |
PRODUCT DOSE OMISSION |
5 |
0.0001 |
| 986 |
JOINT SWELLING |
9 |
0.0001 |
| 987 |
INFLUENZA |
8 |
0.0001 |
| 988 |
SLEEP DISORDER |
5 |
0.0001 |
| 989 |
MUSCULOSKELETAL STIFFNESS |
6 |
0.0001 |
| 990 |
ADVERSE DRUG REACTION |
6 |
0.0001 |
| 991 |
INJECTION SITE ERYTHEMA |
8 |
0.0001 |
| 992 |
DRY MOUTH |
5 |
0.0001 |
| 993 |
FOETAL EXPOSURE DURING PREGNANCY |
5 |
0.0001 |
| 994 |
INFLUENZA LIKE ILLNESS |
5 |
0.0001 |
| 995 |
BREAST CANCER |
5 |
0.0001 |
| 996 |
TOXICITY TO VARIOUS AGENTS |
8 |
0.0000 |
| 997 |
INJECTION SITE PAIN |
13 |
0.0000 |